The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
FYI for a price update?
-
We have a recently approved APS that includes the price of the product. If the price changes, and we make just that one change to the piece, can this be handled with an FYI email?
Hey @charlton
Please send the requested revision in as an FYI and we will assess if it meets the spirit of an FYI request.
